| Trial ID: | L6352 |
| Source ID: | NCT00605787
|
| Associated Drug: |
Tetradecylthioacetic Acid (Tta)
|
| Title: |
TTA in Treatment of Diabetes and Dyslipidemia
|
| Acronym: |
TODDY
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Dyslipidemia
|
| Interventions: |
DRUG: Tetradecylthioacetic acid (TTA)
|
| Outcome Measures: |
Primary: Plasma lipids, -28 days, baseline, 14 and 28 days of TTA | Secondary: Plasma glucose, -28 days, baseline, 14 and 28 days of TTA|Safety blood parameters, -28 days, baseline, 14 and 28 days of TTA
|
| Sponsor/Collaborators: |
Sponsor: Haukeland University Hospital | Collaborators: University of Bergen
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-01
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2008-01-31
|
| Locations: |
Haukeland University Hospital, Bergen, 5021, Norway
|
| URL: |
https://clinicaltrials.gov/show/NCT00605787
|
